NOTTINGHAM ADVISORS, INC. Revance Therapeutics, Inc. Transaction History

NOTTINGHAM ADVISORS, INC. portfolio value:

$359,000
portfolio value

NOTTINGHAM ADVISORS, INC. quarter portfolio value change:

+95.37%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 175K $27 13.31K
Q2 2022 share 0.00% 0 shares -76K $13.82 13.31K
Q1 2022 share 0.00% 0 shares 43K $19.5 13.31K
Q4 2021 share 0.00% 0 shares -154K $16.49 13.31K
Q3 2021 share 0.00% 0 shares -24K $27.86 13.31K
Q2 2021 share 0.00% 0 shares 23K $29.64 13.31K
Q1 2021 share 0.00% 0 shares -5K $27.95 13.31K
Q4 2020 share 0.00% 0 shares 42K $28.34 13.31K
Q3 2020 share 0.00% 0 shares -14K $25.14 13.31K
Q2 2020 share Increase +17.68% 2K shares 182K $24.42 13.31K
Q1 2020 share Increase +13.07% 1.30K shares 5K $14.8 11.31K
Q4 2019 share Decrease -16.66% -2K shares 6K $16.23 10.00K
Q3 2019 share Increase +19.99% 2K shares 26K $13 12.00K
Q2 2019 share 0.00% 0 shares -28K $12.97 10.00K
Q1 2019 share Decrease -11.56% -1.30K shares -123K $15.76 10.00K
Q4 2018 share 0.00% 0 shares 0 $20.13 11.31K
Q3 2018 share 0.00% 0 shares -67K $24.85 11.31K
Q2 2018 share 0.00% 0 shares 0 $27.45 11.31K
Q1 2018 share 0.00% 0 shares -56K $30.8 11.31K
Q4 2017 share 0.00% 0 shares 92K $35.75 11.31K
Q3 2017 share Decrease -15.02% -2K shares -39K $27.55 11.31K
Q2 2017 share 0.00% 0 shares 74K $26.4 13.31K
Q1 2017 share 0.00% 0 shares 1K $20.8 13.31K
Q4 2016 share 0.00% 0 shares 60K $20.7 13.31K
Q3 2016 share Decrease -18.39% -3K shares -6K $16.21 13.31K
Q2 2016 share Decrease -11.00% -2.01K shares -404K $13.6 16.31K
Q1 2016 share 0.00% 0 shares 0 $17.46 18.32K